Tech Company Financing Transactions
Magen BioSciences Funding Round
On 3/31/2006, Magen BioSciences announced $1.8 million in funding from Arch Venture Partners, Lux Capital and TVM Capital.
Transaction Overview
Company Name
Announced On
3/31/2006
Transaction Type
Venture Equity
Amount
$1,840,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
100 Beaver Street 101
Waltham, MA 02453
USA
Waltham, MA 02453
USA
Phone
Website
Email Address
Overview
Magen BioSciences is a specialty pharmaceutical company currently focused on developing proprietary medical therapies for the dermatology market.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brian Gallagher
VP - Bus. Development
Cyrus Mozayeni
VP - R & D
Gordon Letts
Browse more venture capital transactions:
Prev: 3/31/2006: Altela venture capital transaction
Next: 3/31/2006: Adspace Networks venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs